COPD患者への吸入抗コリン剤は心血管死、心筋梗塞、卒中リスク増加 [2008-09-24]以降もまだ当方には製薬会社からの情報が伝達されてない。


Important Information About the Safety of COPD Drugs
Recently, there has been important information released about the safety of drugs used to treat COPD. This information could be of concern and have implications for physicians and their patients. Below are links to some of the articles and studies related to this topic:

* AP Wire article 9-23-08
"Inhaler Lung Drugs Tied to Heart Problems, Deaths"

* JAMA Study Abstract JAMA 2008; 300:1439-1450

* Boehringer Ingelheim Pharmaceuticals, Inc. Press Release 9-23-08
"Established Safety Profile of Spiriva Confirmed by 30 Rigorously Controlled Clinical Trials and the Landmark Trial, UPLIFT; New Data From Landmark UPLIFT Trial Further Supports Spiriva’s Safety Profile"

* UPLIFT (Understanding Potential Long-term impacts on Function with Tiotropium) Safety Study Webcast Summary, Boehringer Ingelheim Pharmaceuticals, Inc.

by internalmedicine | 2008-09-29 15:11 | 呼吸器系  

<< COPD患者の運動中呼吸筋un... 菜食主義者(Vegan)の食事の質 >>